On the filings, Marvell (MRVL) is the stronger stock right now — higher on our blended fundamentals-plus-verdict read, and we currently rate it HOLD.
Real AI-driven 42% growth and a maiden GAAP profit — but ~its multiple and a one-time gain leave the stock priced for perfection.
Record revenue and +23% operating income, but the scary its multiple and -45% earnings are a one-time tax artifact masking a fairly-valued, cyclical IP machine.
| Metric | MRVL | QCOM |
|---|---|---|
| Fundamentals score | 88 | 73 |
| Revenue growth (YoY) | +42.1% | +13.7% |
| Net income growth (YoY) | +401.7% | -45.4% |
| Net margin | 32.6% | 12.5% |
| Return on equity | 18.7% | 26.1% |
| ROIC (est.) | 5.6% | 27.1% |
| Liabilities / Equity | 0.56 | 1.36 |
| Piotroski F-score | 7 / 9 | 6 / 9 |
Bold green = the stronger figure. All rows derive from SEC XBRL filings — no market-price data on this page.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 19, 2026, 2:02 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 7:44 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.